|
1
|
Levey AS and James MT: Acute kidney
injury. Ann Intern Med. 167:ITC66–ITC80. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Niculae A, Gherghina ME, Peride I, Tiglis
M, Nechita AM and Checherita IA: Pathway from acute kidney injury
to chronic kidney disease: Molecules involved in renal fibrosis.
Int J Mol Sci. 24(14019)2023.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Deng Y, Zeng L, Liu H, Zuo A, Zhou J, Yang
Y, You Y, Zhou X, Peng B, Lu H, et al: Silibinin attenuates
ferroptosis in acute kidney injury by targeting FTH1. Redox Biol.
77(103360)2024.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Gonçalves GM, Castoldi A, Braga TT and
Câmara NO: New roles for innate immune response in acute and
chronic kidney injuries. Scand J Immunol. 73:428–435.
2011.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Zhou M, Tang W, Fu Y, Xu X, Wang Z, Lu Y,
Liu F, Yang X, Wei X, Zhang Y, et al: Progranulin protects against
renal ischemia/reperfusion injury in mice. Kidney Int. 87:918–929.
2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Lin J, Wang Q, Zhou S, Xu S and Yao K:
Tetramethylpyrazine: A review on its mechanisms and functions.
Biomed Pharmacother. 150(113005)2022.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Chen HY, Xu DP, Tan GL, Cai W, Zhang GX,
Cui W, Wang JZ, Long C, Sun YW, Yu P, et al: A Potent
multi-functional neuroprotective derivative of tetramethylpyrazine.
J Mol Neurosci. 56:977–987. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Bai XY, Wang XF, Zhang LS, Du PC, Cao Z
and Hou Y: Tetramethylpyrazine ameliorates experimental autoimmune
encephalomyelitis by modulating the inflammatory response. Biochem
Biophys Res Commun. 503:1968–1972. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Wang B, Ni Q, Wang X and Lin L:
Meta-analysis of the clinical effect of ligustrazine on diabetic
nephropathy. Am J Chin Med. 40:25–37. 2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Shao H, Zhao L, Chen F, Zeng S, Liu S and
Li J: Efficacy of ligustrazine injection as adjunctive therapy for
angina pectoris: A systematic review and meta-analysis. Med Sci
Monit. 21:3704–3715. 2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Ni X, Ni X, Liu S and Guo X: Medium- and
long-term efficacy of ligustrazine plus conventional medication on
ischemic stroke: A systematic review and meta-analysis. J Tradit
Chin Med. 33:715–720. 2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Jiang G, Xin R, Yuan W, Zhang L, Meng X,
Sun W, Han H, Hou Y, Wang L and Du P: Ligustrazine ameliorates
acute kidney injury through downregulation of NOD2-mediated
inflammation. Int J Mol Med. 45:731–742. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Sun W, Li A, Wang Z, Sun X, Dong M, Qi F,
Wang L, Zhang Y and Du P: Tetramethylpyrazine alleviates acute
kidney injury by inhibiting NLRP3/HIF-1α and apoptosis. Mol Med
Rep. 22:2655–2664. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Wang M, Zhang L, Huang X and Sun Q:
Ligustrazine promotes hypoxia/reoxygenation-treated trophoblast
cell proliferation and migration by regulating the
microRNA-27a-3p/ATF3 axis. Arch Biochem Biophys.
737(109522)2023.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Jung YY, Mohan CD, Eng H, Narula AS,
Namjoshi OA, Blough BE, Rangappa KS, Sethi G, Kumar AP and Ahn KS:
2,3,5,6-Tetramethylpyrazine targets epithelial-mesenchymal
transition by abrogating manganese superoxide dismutase expression
and TGFβ-driven signaling cascades in colon cancer cells.
Biomolecules. 12(891)2022.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Steinhart Z and Angers S: Wnt signaling in
development and tissue homeostasis. Development.
145(dev146589)2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Liu J, Xiao Q, Xiao J, Niu C, Li Y, Zhang
X, Zhou Z, Shu G and Yin G: Wnt/β-catenin signalling: function,
biological mechanisms, and therapeutic opportunities. Signal
Transduct Target Ther. 7(3)2022.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Schunk SJ, Floege J, Fliser D and Speer T:
WNT-β-catenin signalling-a versatile player in kidney injury and
repair. Nat Rev Nephrol. 17:172–184. 2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Huffstater T, Merryman WD and Gewin LS:
Wnt/β-catenin in acute kidney injury and progression to chronic
kidney disease. Semin Nephrol. 40:126–137. 2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kawakami T, Ren S and Duffield JS: Wnt
signalling in kidney diseases: Dual roles in renal injury and
repair. J Pathol. 229:221–231. 2013.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Tan RJ, Zhou D, Zhou L and Liu Y:
Wnt/β-catenin signaling and kidney fibrosis. Kidney Int Suppl
(2011). 4:84–90. 2014.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Aggarwal S, Wang Z, Rincon Fernandez
Pacheco D, Rinaldi A, Rajewski A, Callemeyn J, Van Loon E,
Lamarthée B, Covarrubias AE, Hou J, et al: SOX9 switch links
regeneration to fibrosis at the single-cell level in mammalian
kidneys. Science. 383(eadd6371)2024.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Ming WH, Luan ZL, Yao Y, Liu HC, Hu SY, Du
CX, Zhang C, Zhao YH, Huang YZ, Sun XW, et al: Pregnane X receptor
activation alleviates renal fibrosis in mice via interacting with
p53 and inhibiting the Wnt7a/β-catenin signaling. Acta Pharmacol
Sin. 44:2075–2090. 2023.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Niehrs C: Function and biological roles of
the dickkopf family of Wnt modulators. Oncogene. 25:7469–7481.
2006.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Ng LF, Kaur P, Bunnag N, Suresh J, Sung
ICH, Tan QH, Gruber J and Tolwinski NS: WNT signaling in disease.
Cells. 8(826)2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Lin CL, Wang JY, Ko JY, Huang YT, Kuo YH
and Wang FS: Dickkopf-1 promotes hyperglycemia-induced accumulation
of mesangial matrix and renal dysfunction. J Am Soc Nephrol.
21:124–135. 2010.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Tveita AA and Rekvig OP: Alterations in
Wnt pathway activity in mouse serum and kidneys during lupus
development. Arthritis Rheum. 63:513–522. 2011.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Klavdianou K, Liossis SN and Daoussis D:
Dkk1: A key molecule in joint remodelling and fibrosis. Mediterr J
Rheumatol. 28:174–182. 2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Hsu YC, Chang CC, Hsieh CC, Huang YT, Shih
YH, Chang HC, Chang PJ and Lin CL: Dickkopf-1 acts as a profibrotic
mediator in progressive chronic kidney disease. Int J Mol Sci.
24(7679)2023.PubMed/NCBI View Article : Google Scholar
|
|
30
|
National Research Council (US) Committee
for the Update of the Guide for the Care and Use of Laboratory
Animals. Guide for the care and use of laboratory animals, 8th
edition. Washington (DC): National Academies Press (US), 2011.
|
|
31
|
Office of the Institutional Animal Care
and Use Committee, The University of Iowa: Anesthesia (Guideline).
https://animal.research.uiowa.edu/iacuc-guidelines-anesthesia.
Accessed August 21, 2025.
|
|
32
|
Charan J and Kantharia ND: How to
calculate sample size in animal studies? J Pharmacol Pharmacother.
4:303–306. 2013.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Pickkers P, Darmon M, Hoste E, Joannidis
M, Legrand M, Ostermann M, Prowle JR, Schneider A and Schetz M:
Acute kidney injury in the critically ill: An updated review on
pathophysiology and management. Intensive Care Med. 47:835–850.
2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Ostermann M, Lumlertgul N, Jeong R, See E,
Joannidis M and James M: Acute kidney injury. Lancet. 405:241–256.
2025.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Mehrotra P, Sturek M, Neyra JA and Basile
DP: Calcium channel Orai1 promotes lymphocyte IL-17 expression and
progressive kidney injury. J Clin Invest. 129:4951–4961.
2019.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Kar F, Hacioglu C, Senturk H, Donmez DB
and Kanbak G: The role of oxidative stress, renal inflammation, and
apoptosis in post ischemic reperfusion injury of kidney tissue: The
protective effect of dose-dependent boric acid administration. Biol
Trace Elem Res. 195:150–158. 2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Chi F, Feng L, Li Y, Zhao S, Yuan W, Jiang
Y and Cheng L: MiR-30b-5p promotes myocardial cell apoptosis in
rats with myocardial infarction through regulating Wnt/β-catenin
signaling pathway. Minerva Med. 114:476–484. 2023.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Sun JD, Li XM, Liu JL, Li J and Zhou H:
Effects of miR-150-5p on cerebral infarction rats by regulating the
Wnt signaling pathway via p53. Eur Rev Med Pharmacol Sci.
24:3882–3891. 2020.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Chen X, Tan H, Xu J, Tian Y, Yuan Q, Zuo
Y, Chen Q, Hong X, Fu H, Hou FF, et al: Klotho-derived peptide 6
ameliorates diabetic kidney disease by targeting Wnt/β-catenin
signaling. Kidney Int. 102:506–520. 2022.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Al-Salam S, Jagadeesh GS, Sudhadevi M and
Yasin J: Galectin-3 and autophagy in renal acute tubular necrosis.
Int J Mol Sci. 25(3604)2024.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Meng P, Zhu M, Ling X and Zhou L: Wnt
signaling in kidney: The initiator or terminator? J Mol Med (Berl).
98:1511–1523. 2020.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Li SS, Sun Q, Hua MR, Suo P, Chen JR, Yu
XY and Zhao YY: Targeting the Wnt/β-catenin signaling pathway as a
potential therapeutic strategy in renal tubulointerstitial
fibrosis. Front Pharmacol. 12(719880)2021.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Zhou L and Liu Y: Wnt/β-catenin signalling
and podocyte dysfunction in proteinuric kidney disease. Nat Rev
Nephrol. 11:535–545. 2015.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Tao H, Chen F, Liu H, Hu Y, Wang Y and Li
H: Wnt/β-catenin signaling pathway activation reverses gemcitabine
resistance by attenuating Beclin1-mediated autophagy in the MG63
human osteosarcoma cell line. Mol Med Rep. 16:1701–1706.
2017.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Menon NA, Kumar CD, Ramachandran P, Blaize
B, Gautam M, Cordani M and Kumar LD: Small-molecule inhibitors of
WNT signalling in cancer therapy and their links to autophagy and
apoptosis. Eur J Pharmacol. 986(177137)2025.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Ma Q, Yu J, Zhang X, Wu X and Deng G:
Wnt/β-catenin signaling pathway-a versatile player in apoptosis and
autophagy. Biochimie. 211:57–67. 2023.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Chen X, Wang CC, Song SM, Wei SY, Li JS,
Zhao SL and Li B: The administration of erythropoietin attenuates
kidney injury induced by ischemia/reperfusion with increased
activation of Wnt/β-catenin signaling. J Formos Med Assoc.
114:430–437. 2015.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Xiao L, Zhou D, Tan RJ, Fu H, Zhou L, Hou
FF and Liu Y: Sustained activation of Wnt/β-catenin signaling
drives AKI to CKD progression. J Am Soc Nephrol. 27:1727–1740.
2016.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Baetta R and Banfi C: Dkk (dickkopf)
proteins. Arterioscler Thromb Vasc Biol. 39:1330–1342.
2019.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Liang L, He H, Lv R, Zhang M, Huang H, An
Z and Li S: Preliminary mechanism on the methylation modification
of Dkk-1 and Dkk-3 in hepatocellular carcinoma. Tumour Biol.
36:1245–1250. 2015.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Li YH, Cheng YC, Wu J and Lee IT: Plasma
dickkopf-1 levels are associated with chronic kidney disease.
Metabolites. 15(300)2025.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Hung PH, Hsu YC, Chen TH, Ho C and Lin CL:
The histone demethylase inhibitor GSK-J4 Is a therapeutic target
for the kidney fibrosis of diabetic kidney disease via DKK1
modulation. Int J Mol Sci. 23(9407)2022.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Zhang H, Du D, Gao X, Tian X, Xu Y, Wang
B, Yang S, Liu P and Li Z: PFT-α protects the blood-brain barrier
through the Wnt/β-catenin pathway after acute ischemic stroke.
Funct Integr Genomics. 23(314)2023.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Wo D, Peng J, Ren DN, Qiu L, Chen J, Zhu
Y, Yan Y, Yan H, Wu J, Ma E, et al: Opposing roles of Wnt
inhibitors IGFBP-4 and Dkk1 in cardiac ischemia by differential
targeting of LRP5/6 and β-catenin. Circulation. 134:1991–2007.
2016.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Li X, Liu XL, Li X, Zhao YC, Wang QQ,
Zhong HY, Liu DD, Yuan C, Zheng TF and Zhang M: Dickkopf1 (Dkk1)
alleviates vascular calcification by regulating the degradation of
phospholipase D1 (PLD1). J Cardiovasc Transl Res. 15:1327–1339.
2022.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Yuan S, Hoggard NK, Kantake N, Hildreth BE
III and Rosol TJ: Effects of dickkopf-1 (DKK-1) on prostate cancer
growth and bone metastasis. Cells. 12(2695)2023.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Zou Y, Zhao D, Yan C, Ji Y, Liu J, Xu J,
Lai Y, Tian J, Zhang Y and Huang Z: Novel ligustrazine-based
analogs of piperlongumine potently suppress proliferation and
metastasis of colorectal cancer cells in vitro and in vivo. J Med
Chem. 61:1821–1832. 2018.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Albrecht LV, Tejeda-Muñoz N and De
Robertis EM: Cell biology of canonical Wnt signaling. Annu Rev Cell
Dev Biol. 37:369–389. 2021.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Gao C and Chen YG: Dishevelled: The hub of
Wnt signaling. Cell Signal. 22:717–727. 2010.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Cruciat CM and Niehrs C: Secreted and
transmembrane wnt inhibitors and activators. Cold Spring Harb
Perspect Biol. 5(a015081)2013.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Farnhammer F, Colozza G and Kim J: RNF43
and ZNRF3 in Wnt signaling-A master regulator at the membrane. Int
J Stem Cells. 16:376–384. 2023.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Gao Y, Chen N, Fu Z and Zhang Q: Progress
of Wnt signaling pathway in osteoporosis. Biomolecules.
13(483)2023.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Fetisov TI, Lesovaya EA, Yakubovskaya MG,
Kirsanov KI and Belitsky GA: Alterations in WNT signaling in
leukemias. Biochemistry (Mosc). 83:1448–1458. 2018.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Ho HYH: The tale of capturing Norrin.
Elife. 13(e98933)2024.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Raslan AA and Yoon JK: R-spondins:
Multi-mode WNT signaling regulators in adult stem cells. Int J
Biochem Cell Biol. 106:26–34. 2019.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Zou J, Gao P, Hao X, Xu H, Zhan P and Liu
X: Recent progress in the structural modification and
pharmacological activities of ligustrazine derivatives. Eur J Med
Chem. 147:150–162. 2018.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Chen Q, Zhang D, Bi Y, Zhang W, Zhang Y,
Meng Q, Li Y and Bian H: The protective effects of liguzinediol on
congestive heart failure induced by myocardial infarction and its
relative mechanism. Chin Med. 15(63)2020.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Li L, Zhang D, Yao W, Wu Z, Cheng J, Ji Y,
Dong L, Zhao C and Wang H: Ligustrazine exerts neuroprotective
effects via circ_0008146/miR-709/Cx3cr1 axis to inhibit cell
apoptosis and inflammation after cerebral ischemia/reperfusion
injury. Brain Res Bull. 190:244–255. 2022.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Rai U, Kosuru R, Prakash S, Tiwari V and
Singh S: Tetramethylpyrazine alleviates diabetic nephropathy
through the activation of Akt signalling pathway in rats. Eur J
Pharmacol. 865(172763)2019.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Yang QH, Liang Y, Xu Q, Zhang Y, Xiao L
and Si LY: Protective effect of tetramethylpyrazine isolated from
Ligusticum chuanxiong on nephropathy in rats with
streptozotocin-induced diabetes. Phytomedicine. 18:1148–1152.
2011.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Avila-Carrasco L, Majano P, Sánchez-Toméro
JA, Selgas R, López-Cabrera M, Aguilera A and González Mateo G:
Natural plants compounds as modulators of epithelial-to-mesenchymal
transition. Front Pharmacol. 10(715)2019.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Liu SP, Shibu MA, Tsai FJ, Hsu YM, Tsai
CH, Chung JG, Yang JS, Tang CH, Wang S, Li Q and Huang CY:
Tetramethylpyrazine reverses high-glucose induced hypoxic effects
by negatively regulating HIF-1α induced BNIP3 expression to
ameliorate H9c2 cardiomyoblast apoptosis. Nutr Metab (Lond).
17(12)2020.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Dhaliwal J, Dhaliwal N, Akhtar A, Kuhad A
and Chopra K: Tetramethylpyrazine attenuates cognitive impairment
via suppressing oxidative stress, neuroinflammation, and apoptosis
in type 2 diabetic rats. Neurochem Res. 47:2431–2444.
2022.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Fan Y and Wu Y: Tetramethylpyrazine
alleviates neural apoptosis in injured spinal cord via the
downregulation of miR-214-3p. Biomed Pharmacother. 94:827–833.
2017.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Matuszkiewicz-Rowińska J and Małyszko J:
Acute kidney injury, its definition, and treatment in adults:
Guidelines and reality. Pol Arch Intern Med. 130:1074–1080.
2020.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Li J and Gong X: Tetramethylpyrazine: An
active ingredient of Chinese herbal medicine with therapeutic
potential in acute kidney injury and renal fibrosis. Front
Pharmacol. 13(820071)2022.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Li J, Li T, Li Z, Song Z and Gong X:
Potential therapeutic effects of Chinese meteria medica in
mitigating drug-induced acute kidney injury. Front Pharmacol.
14(1153297)2023.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Ko MJ and Lim CY: General considerations
for sample size estimation in animal study. Korean J Anesthesiol.
74:23–29. 2021.PubMed/NCBI View Article : Google Scholar
|
